BOT 0.00% 32.5¢ botanix pharmaceuticals ltd

Ann: Upcoming BTX 1801 Data Presentations at European Congress, page-8

  1. 1,758 Posts.
    lightbulb Created with Sketch. 1161
    Am I right in saying this data is nothing new and has already been shared with the market following the 1801 Phase 2a study, which was received less than excitedly by the market? I mean it's an excellent opportunity to continue to showcase that we are onto something that is going somewhere, but this is really just another advertising opportunity to maybe wake up a bit more of the market to BOT, is it not? Maybe a couple of cents in it if we're lucky? Genuinely asking.
    Last edited by Grainofsand: 13/04/22
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.